TickerFacts.

Mineralys Therapeutics, Inc. (MLYS): EPS (Basic)

Annual figures by period end, from SEC filings.

-$2.29
Year ended 2025-12-31
2022-12-31: -$5.772023-12-31: -$1.992024-12-31: -$3.662025-12-31: -$2.29-$2.29
2022-12-31 EPS (Basic) (USD per share) 2025-12-31
Period endedEPS (Basic)Change YoYSource filing
2025-12-31-$2.29n/m2026-03-12, From 2025-01-01
2024-12-31-$3.66n/m2026-03-12, From 2024-01-01
2023-12-31-$1.99n/m2025-02-12, From 2023-01-01
2022-12-31-$5.77n/a2024-03-21, From 2022-01-01

EPS (Basic) at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedEPS (Basic)Change YoY
Mineralys Therapeutics, Inc. (MLYS)2025-12-31-$2.29n/m
Protagonist Therapeutics, Inc (PTGX)2025-12-31-$2.05n/m
Amarin Corp PLC (AMRN)2025-12-31-$0.09n/m
Immunome Inc. (IMNM)2025-12-31-$2.43n/m
Wave Life Sciences, Inc. (WVE)2025-12-31-$1.21n/m
Nurix Therapeutics, Inc. (NRIX)2025-11-30-$3.05n/m
Axsome Therapeutics, Inc. (AXSM)2025-12-31-$3.68n/m
Xenon Pharmaceuticals Inc. (XENE)2025-12-31-$4.36n/m
Viking Therapeutics, Inc. (VKTX)2025-12-31-$3.19n/m

Compare MLYS, PTGX, AMRN, IMNM side by side · Screen every company in Pharmaceutical Preparations ↗